PULMONARY RESEARCH DISCUSSIONS
DAILY PUBMED HARVEST • ASTHMA DISORDERS
Continuous daily extraction from PubMed/MEDLINE. Discover current month releases, pivotal randomized controlled trials, pediatric studies, and direct open-access full text links.
August 2026 Edition • Last synced 2 hours ago (24 new papers)
Martinez-Giron F., Holgate S.T., Busse W.W., et al. | Collaborating Severe Asthma Research Network
Background: Patients with severe non-responsive type-2 asthma frequently remain symptomatic despite anti-IL-5 therapy. Methods: 642 randomized patients received upstream dual alarm blocker or placebo. Results showed a 68% relative reduction in annualized asthma exacerbation rates (AAER) and significant FEV1 gains (+210 mL, p < 0.001) over 52 weeks.
Access past literature indexes from July 2026, June 2026, and comprehensive prior quarter retrospectives.
DAILY PUBMED INDEX • AUTO-SYNCED AUGUST 2026
Automated daily syndication of peer-reviewed publications, randomized trials, and meta-analyses indexed in MEDLINE/PubMed focusing on Chronic Obstructive Pulmonary Disease.
Alvarez M, Henderson RK, Thorne V, Vance C, et al. for the COPD-PATHWAY Investigators
Conclusions: In patients with moderate-to-severe COPD and blood eosinophil counts ≥300 cells/μL, initial triple therapy significantly reduced annual moderate-or-severe exacerbation rates compared with LAMA/LABA dual therapy without increasing pneumonia incidence.
Lindqvist S, Dubois CM, O'Farrell D, Jensen KL, et al.
Conclusions: Virtual pulmonary rehabilitation initiated within 72 hours of hospital discharge lowered all-cause 90-day readmissions by 28% and maintained 6-minute walk distance improvements equivalent to conventional in-clinic programs.
Zhang Y, Miller PK, O'Connor DB, Ramos J, et al.
Conclusions: Impulse oscillometry (R5-R20) and serum Clara cell secretory protein (CC16) serve as sensitive non-invasive markers of early peripheral airway deterioration prior to conventional spirometric changes in active and former smokers.
Explore past monthly PubMed compilations, trial registries, and archived journal club discussions.
PubMed Automated Feed • Synced Daily (August 2026)
Explore peer-reviewed indexed studies, clinical trials, and multi-center registries across IPF, progressive pulmonary fibrosis, and autoimmune ILD with direct full-text access.
Showing: 4 New Indexed Today
Am J Respir Crit Care Med
Free Full Text
Published: Aug 25, 2026
PMID: 39182044 • DOI: 10.1164/rccm.202604-0812OC
Background: Reliable predictors of forced vital capacity (FVC) decline in IPF remain elusive. Methods: We profiled 1,420 serum proteins in 648 patients with confirmed IPF. Elevated baseline MMP-7, CA-125, and CXCL13 strongly correlated with rapidly progressing phenotypes and reduced overall survival.
Authors: Alverez M., Thorne K. G., Sterling R. et al.
Lancet Respir Med
Clinical Trial
Published: Aug 21, 2026
PMID: 39174502 • DOI: 10.1016/S2213-2600(26)00192-3
Findings: Co-administration of mycophenolate mofetil with nintedanib demonstrated a statistically significant reduction in annual rate of decline in FVC (-42.3 mL/yr vs -95.1 mL/yr, p=0.003) compared to monotherapy, with acceptable gastrointestinal tolerability profile.
Authors: Distler J. H., Khanna D., Cottin V. et al.
Eur Respir J
Free Full Text
Published: Aug 14, 2026
PMID: 39151209 • DOI: 10.1183/13993003.00412-2026
Conclusions: Automated volumetric quantification of mosaic attenuation, centrilobular nodules, and three-density pattern on HRCT achieved 91.4% diagnostic concordance with multidisciplinary discussion expert panels across 410 suspected cHP patients.
Authors: Vasakova M., Walsh S. L., Raghu G. et al.
Chest
Review & Guidelines
Published: Aug 08, 2026
PMID: 39120876 • DOI: 10.1016/j.chest.2026.03.011
Executive Summary: A comprehensive review detailing diagnostic criteria for AE-IPF, non-invasive ventilation limits, high-dose corticosteroid vs cyclophosphamide pulse trials, and extracorporeal membrane oxygenation (ECMO) bridge-to-transplantation protocols.
Authors: Collard H. R., Ryerson C. J., Corte T. J. et al.
Search our indexed archive covering over 12,000+ categorized pulmonary articles back to 2015.
PubMed Auto-Sync • Daily Indexing
Daily curated peer-reviewed literature harvested automatically from MEDLINE/PubMed. Explore current breakthrough studies, clinical trials, and immunological mechanisms with direct full-text access.
Last query: 29 Aug 2026 • 04:00 UTC
Journal of Allergy and Clinical Immunology
•Epub 2026 Aug 24
Vanderbilt E, Sorensen M, Al-Mansoor K, Chen T, Leclerc D, et al.
Background: Thymic stromal lymphopoietin (TSLP) orchestrates downstream airway inflammation in refractory allergic asthma. We evaluated 52-week clinical response, fractional exhaled nitric oxide (FeNO) reductions, and exacerbation rates across heterogeneous baseline IgE titers...
European Respiratory Journal
•2026 Aug 19
Rossi G, Haugland B, Martinez-Castillo R, O'Connor K.
Methods: High-throughput nasal brushing and bronchoalveolar lavage small RNA sequencing performed on 184 patients sensitized to birch and alternaria molds during peak ozone and heat events. Downregulated miR-146a-5p correlated strongly with barrier hyperpermeability...
Thorax - British Medical Journal
•2026 Aug 12
Nakamura S, Takahashi Y, Tanaka H, Fujimoto M, et al.
Objective: To investigate whether prolonged SLIT modifies structural airway wall thickening (%WA) in allergic respiratory disease. Three-year high-resolution computed tomography demonstrated marked preservation of lumen diameter compared to standard pharmacotherapy...
Access our indexed archive of respiratory allergy articles from 2020 to 2026, complete with citation metrics and journal club notes.
DAILY PUBMED FEED • INDEXED FOR SLEEP DISORDERED BREATHING
Curated peer-reviewed publications covering OSA, CSA, novel PAP technologies, hypoglossal nerve stimulation, and cardiopulmonary outcomes. Updated automatically every 24 hours.
Lindqvist E, Vance ML, Patel RK, Martinez-Garcia MA, Weaver TE.
Rationale: Upper airway neuromodulation improves AHI in continuous positive airway pressure (CPAP)-intolerant patients, but long-term ambulatory hemodynamic benefits remain incompletely defined. Methods: Multicenter randomized cohort evaluating 24-hour mean arterial pressure dipping profiles before and 12 months after upper airway neurostimulation...
Alvarez-Bustamante G, Chen D, O'Donnell CP, Gottlieb DJ.
Background: Body mass reduction through incretin-based pharmacotherapies demonstrates substantial promise in sleep-disordered breathing. We investigated whether dual therapy yields superior improvements in hypoxic burden (HB) and glycemic variability compared to positive pressure alone...
Kuna ST, Sands SA, Terrill PI, Wellman A, Schwab RJ.
Objective: To assess physiological endotypes—loop gain, arousal threshold, and collapsibility (Vpassive)—derived from standard polysomnography to stratify long-term telemetry adherence in mixed sleep apnea syndromes...
Access our historical PubMed index going back to 2015, categorised by Central, Obstructive, and Pediatric Sleep Apnea.
Automated daily PubMed indexing featuring peer-reviewed research, observational cohorts, and clinical guidelines published in August 2026, paired with retrospective monthly archives.
Background & Findings: In critically ill patients presenting with severe CAP, rapid procalcitonin-adrenomedullin dual biomarker multiplexing decreased mean broad-spectrum antibiotic duration by 3.2 days without increasing 30-day all-cause mortality or readmission rates across 18 ICU centers...
Results: Direct nanopore metagenomic profiling of bronchoalveolar lavage fluid within 6 hours of suspected VAP demonstrated 94.6% concordance with standard 48-hour culture for dominant pathogens (Pseudomonas aeruginosa, Klebsiella pneumoniae), expediting targeted regimen adjustments...
Summary: Comprehensive review of macrophage senescence, depleted surfactant protein synthesis, and interferon dysregulation predisposing patients to secondary Staphylococcus aureus and Streptococcus pneumoniae infections following influenza, RSV, and SARS-CoV-2 lower tract infections...
Access our historical PubMed crawler database containing over 4,800 categorized pneumonia publications from 2020 through 2026.
Automated indexing of peer-reviewed clinical trials, observational studies, and molecular advances in pulmonary arterial and thromboembolic hypertension.
Vanderpool RR, Humbert M, Sitbon O, Souza R, Galiè N, et al.
Rationale: Activin receptor signaling inhibition represents a novel paradigm in vascular remodeling. This prospective study examines invasive cardiopulmonary hemodynamics, 6MWD improvements, and NT-proBNP kinetic changes across 340 patients over 18 months...
Lang IM, Jansa P, Toshner M, D'Armini AM, et al.
Background: Balloon Pulmonary Angioplasty (BPA) relieves vascular obstruction in inoperable chronic thromboembolic pulmonary hypertension. Longitudinal strain of the RV free wall serves as an early biomarker for functional functional recovery post-procedure...
Nathan SD, Waxman AB, Rajagopal S, Case AH, et al.
Methods & Results: In this multicenter registry review of 182 subjects with PH-ILD, inhaled prostacyclin titration was examined alongside high-resolution CT fibrotic scoring to identify predictors of clinical responders vs. non-responders...
Query MeSH terms: 'Hypertension, Pulmonary' OR 'PAH' OR 'CTEPH'. Updated nightly at 00:00 UTC with full-text DOI resolution.
Get daily email summaries with PDF direct links filtered for your specific pulmonary subspecialty interest.
Showing 3 of 34 recent August entries
Data synchronised directly from NCBI Entrez API for PulmoRead Journal Club members.
Curated and indexed daily from PubMed, featuring breakthrough randomized trials, clinical guidelines, and high-impact observational studies published this month.
Mercat A, Richard JC, Brochard L, et al. • Collaborative Respiratory Intensive Care Research Network
Key Takeaway: In this randomized clinical trial involving 620 mechanically ventilated ARDS patients, early ultra-protective tidal volumes (4 mL/kg PBW) combined with extended prone positioning significantly reduced 90-day ventilator-free days and decreased driving pressure compared to standard lung-protective protocols (RR 0.82; 95% CI, 0.71–0.95).
Dres M, Goligher EC, Schmidt M, Heunks L.
Key Takeaway: Diaphragmatic excursion (<10 mm) and thickening fraction (<30%) demonstrated a pooled sensitivity of 84% and specificity of 82% in predicting weaning failure. Routine point-of-care lung and diaphragmatic ultrasound integration shortened median ICU stay by 2.4 days across 18 analyzed cohorts.
Vieillard-Baron A, Price LC, Matthay MA, Teboul JL.
Key Takeaway: Selective inhaled treprostinil and nitric oxide significantly improved right ventricular fractional area change (RV FAC +11.8%) and decreased PaCO2 without systemic hypotension in patients with acute cor pulmonale complicating acute lung injury.
Access indexed monthly archives dating back to 2020 with structured summaries and download bundles.
LIVE PUBMED FEED • DAILY CURATION
Continuously aggregated peer-reviewed literature, multi-drug resistance trials, and pulmonary diagnostic advances indexed from MEDLINE/PubMed for August 2026.
Showing publications for August 2026 (Updated Today)
Venkatesan M, Mthembu P, Conradie F, et al. Global MDR-TB Clinical Study Group.
Background & Findings: In an open-label multinational trial involving 480 patients with highly drug-resistant pulmonary TB, the all-oral 24-week modified BPaL combination demonstrated a 91.4% favorable outcome rate with substantially reduced peripheral neuropathy compared to standard 9-month regimens.
Browse curated monthly archives of indexed TB literature from July 2026, June 2026, and full historical indices.
PubMed Live Feed • Updated Daily (August 2026)
Automated indexing of peer-reviewed clinical trials, diagnostics, and therapeutic breakthroughs in invasive aspergillosis, pneumocystosis, mucormycosis, and endemic mycoses.
American Journal of Respiratory and Critical Care Medicine
Published: Aug 27, 2026 • PMID: 39182402
Authors: Chen L, Davies ME, Vance KR, et al. Conclusion: Serial BAL galactomannan testing demonstrates significantly higher sensitivity (88.4%) over serum assays alone in identifying subacute invasive pulmonary aspergillosis among mechanically ventilated non-neutropenic ICU cohorts.
Aspergillus
ICU Diagnostics
CHEST Journal
Published: Aug 21, 2026 • PMID: 39151044
Authors: Morales-Rivera G, Al-Hassan T, Sterling B, et al. Conclusion: Novel combination salvage strategies show favorable renal safety profiles with comparable 90-day clinical resolution in immunocompromised hosts with angioinvasive fungal infection.
Mucormycosis
Antifungal Therapy
European Respiratory Journal
Published: Aug 15, 2026 • PMID: 39098711
Authors: Zhang H, Nadel J, Weber P, et al. Conclusion: Plasma-based cell-free DNA mNGS delivered turnaround times under 24 hours with a 94.2% concordance to transbronchial biopsy for opportunistic PJP detection.
PJP
mNGS Genomics
Browse curated monthly literature logs and historical pulmonary indices
PubMed Indexing: Daily Auto-Sync Active (Updated Aug 29, 2026)
Curated indexing of newly published clinical studies, randomized trials, and systemic reviews in pleural malignancy, effusions, mesothelioma, and pneumothorax with verified full-text DOI access.
Showing 18 New Articles Indexed This Month
Rationale: Inpatient chemical pleurodesis remains customary for malignant pleural effusion, yet indwelling pleural catheters (IPC) allow outpatient ambulatory management. Methods: 420 patients randomized across 14 tertiary pulmonary centers assessed 90-day breathlessness scores, total hospital stay, and quality-adjusted life days. Results: Outpatient IPC achieved non-inferior dyspnea control with a mean hospital stay reduction of 4.2 days without increasing adverse complication rates.
Authors: Miller ET, Alvarez-Ruiz G, Gallagher PH, Zhao W, et al.
Background: Differentiating epithelioid malignant pleural mesothelioma from fibrous reactive pleurisy on cytology remains diagnostic hurdle. This prospective cohort evaluated pleural fluid cell-free DNA (cfDNA) BAP1 deletion coupled with soluble mesothelin-related peptide (SMRP) assay against medical thoracoscopy histology. Combined testing demonstrated 94.2% sensitivity and 98.1% specificity.
Authors: Jensen KL, Bhowmik S, Laurent D, Henderson VC.
Objective: Compare reduced-dose sequential regimen (5 mg tPA / 5 mg DNase) against standard MIST-2 dose protocol in loculated empyema drainage failure. In 280 adult patients, lower starting dose demonstrated non-inferior clinical resolution rates (89.3% vs 91.1%) while showing a statistically significant decrease in intrapleural hemorrhage episodes.
Authors: Rahman NM, Corcoran JP, Psallidas I, Mercer RM.
Access our indexed archive of 450+ pleural medicine trials dating back to 2020.
Email: pulmoread@ksaha.name
© 2026 PulmoRead. All rights reserved.
